Research
The Trauma and Transfusion Medicine Research Center (TTMRC) at the University of Pittsburgh is a multidisciplinary research center engaged in improving the outcomes of patients with traumatic injury and for patients requiring transfusion through innovative research.
We have an integrated team of surgeon-scientists, basic science researchers, epidemiologists, computational and systems biologists engaged in interdisciplinary collaborative research projects with a common goal i.e. Improving the outcomes and saving lives from acute injury and for those who need blood transfusions.
The TTMRC serves as a nexus for collaboration in trauma research for the Pittsburgh community and beyond, building on the combined strengths of our faculty, member institutions, scientific working groups, affiliate members, and industry partners. Our members use a broad range of experimental systems and state-of-the-art quantitative and qualitative research methods to understand human responses to trauma to develop intervention programs to ameliorate its consequences.
Transfusion and Hemostatic Therapies
Transfusion and hemostatic therapies are essential for managing blood loss and restoring hemostasis in patients with bleeding disorders, trauma, or during surgical procedures. These treatments involve the administration of blood components—including red blood cells, platelets, and plasma—as well as specialized agents that promote clot formation and stabilize bleeding.
Our research focuses on evidence-based transfusion protocols to ensure safe, effective, and timely treatment. By combining advanced transfusion practices with targeted hemostatic interventions, we aim to optimize patient outcomes, reduce complications, and support recovery in both emergency care and planned surgical settings.
Trauma
Physical trauma refers to injuries caused by external forces such as accidents, falls, sports injuries, or violence. These injuries can range from minor cuts and bruises to severe damage involving bones, muscles, organs, or tissues. Our research investigates the immediate and long-term effects of physical trauma, including healing processes, complications, and rehabilitation strategies.
Advancements in trauma research aim to improve emergency care, surgical techniques, and recovery outcomes, ultimately reducing disability and enhancing quality of life for patients.
Hemostasis
Our hemostasis research focuses on understanding the body’s natural process of stopping bleeding and maintaining vascular integrity. Hemostasis involves a complex interaction between blood vessels, platelets, and clotting factors to prevent excessive blood loss after injury. We investigate:
Mechanisms of Blood Clot Formation – Exploring platelet function and coagulation pathways.
Disorders of Hemostasis – Studying conditions such as hemophilia, von Willebrand disease, and bleeding complications.
Innovative Therapies – Developing targeted treatments to improve surgical outcomes and trauma care.
Through advanced laboratory techniques and clinical studies, our research aims to improve patient safety, optimize bleeding management, and reduce complications in trauma, surgery, and cardiovascular care.
Thrombosis
Our thrombosis research focuses on understanding the mechanisms behind abnormal blood clot formation and its impact on health. Thrombosis occurs when a blood clot obstructs a vessel, potentially leading to serious conditions such as deep vein thrombosis (DVT), pulmonary embolism, stroke, or heart attack. We investigate:
Pathways of Clot Formation – Studying platelet activation and coagulation processes.
Risk Factors and Prevention – Identifying genetic, lifestyle, and clinical contributors to thrombosis.
Innovative Treatments – Developing safer anticoagulant therapies and personalized medicine approaches.
Our goal is to advance knowledge in vascular biology, improve thrombosis prevention, and enhance patient outcomes through cutting-edge research and clinical collaboration.